Insurance for Biotechs: Property 3089635636924505613-blid-9207544903776115121

ป้าป่วยมะเร็ง ถูกรางวัลที่ 1 สุดดีใจเก็บไว้ใช้รักษาตัว

Biotechnology companies and organisations display distinctive features and, from an insurance perspective, uncommon risks. Quite apart from liability risks associated with the testing of investigational drugs, biotech companies are faced with some unique exposures that could delay development, and possibly, the achievement of milestones. Such delays could hamper the ability of the company to raise additional funds and therefore its ability to continue as a going concern.